疾病
糖尿病肾病
疾病分类:urinary system disorder/metabolic disease/kidney disorder/chronic kidney disease/human disease/disease by body system or component
疾病介绍
糖尿病肾病是糖尿病患者发生的进行性肾脏损伤,与肾小球毛细血管的血管损害有关,可伴随肾小球硬化。
标准定义来源:MONDO:0005016 diabetic kidney disease · 本体版本 2026-10-06
参考文献
- Noshahr Zahra Samadi, Salmani Hossein, Khajavi Rad Abolfazl, Sahebkar Amirhossein. Animal Models of Diabetes-Associated Renal Injury. Journal of Diabetes Research. 2020.
- Hang Xing, Ma Jiang, Wei Yu, Wang Yayun, Zang Xiaoyu, Xie Pengfei, Zhang Lili, Zhao Linhua. Renal microcirculation and mechanisms in diabetic kidney disease. Frontiers in Endocrinology. 2025.
- He Huijun, Wang Honglian, Chen Xiaocui, Zhong Yu, Huang Xiao Ru, Ma Ronald CW, Wang Cheng, Lan Hui-Yao. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling. International Journal of Biological Sciences. 2024.
- Xie Kang, Ma Yan, Din Jingjing, Jin Yujie, Zhang Siwen, Liu Shiqiang, Yu Cui, Wu Xu, Xing Chunyan, Wang Lizhuo, Gao Jialin. Research and advances in mouse models of diabetic nephropathy: a narrative review. BMC Nephrology. 2025.
- Zhuang Yibo, Fu Chenlu, Guo Zheng, Xu Yan, Zhou Jun, Ni Huiping, Zhang Aihua. GABA ameliorates diabetic kidney disease-induced podocyte injury via JAML-FPR2 axis-mediated suppression of macrophage infiltration. Renal Failure. 2026.
- Brosius Frank C., Alpers Charles E.. New Targets for Treatment of Diabetic Nephropathy: What We Have Learned from Animal Models. Current opinion in nephrology and hypertension. 2013.
- Lai Yubo, Zhang Liang, Tao Wenxin, An Jieyuan, Wang Lantian, Liu Zhaoyou, Yang Guodong, Wu Pengying, Yuan Lijun. Low‐Intensity Ultrasound‐Triggered Microbubble Cavitation Attenuates Diabetic Kidney Injury Partially by Reversing Endothelial Dysfunction. Advanced Science. 2026.
- Liang Jianqing, Liu Youhua. Animal Models of Kidney Disease: Challenges and Perspectives. Kidney360. 2023.
- Brosius Frank C., Alpers Charles E., Bottinger Erwin P., Breyer Matthew D., Coffman Thomas M., Gurley Susan B., Harris Raymond C., Kakoki Masao, Kretzler Matthias, Leiter Edward H., Levi Moshe, McIndoe Richard A., Sharma Kumar, Smithies Oliver, Susztak Katalin, Takahashi Nobuyuki, Takahashi Takamune. Mouse Models of Diabetic Nephropathy. Journal of the American Society of Nephrology : JASN. 2009.
- Shahzad Zenab, Bala Niharika, Illyas Arooba, Kazory Amir, Chandrasekar Indra, Alli Abdel A.. Dapagliflozin Attenuates NKCC2 Protein Expression and Alleviates Diabetic Kidney Disease in Salt Loaded‐Hypertensive Diabetic Db/Db Mice. FASEB BioAdvances. 2026.
- Xu Fang, Jiang Hongwei, Li Xiaozhou, Pan Jian, Li Huiling, Wang Luxiang, Zhang Pan, Chen Junxiang, Qiu Shuangfa, Xie Yuxin, Li Yijian, Zhang Dongshan, Dong Zheng. Discovery of PRDM16‐Mediated TRPA1 Induction as the Mechanism for Low Tubulo‐Interstitial Fibrosis in Diabetic Kidney Disease. Advanced Science. 2023.
- Xiao Li, Xu Xiaoxuan, Zhang Fan, Wang Ming, Xu Yan, Tang Dan, Wang Jiahui, Qin Yan, Liu Yu, Tang Chengyuan, He Liyu, Greka Anna, Zhou Zhiguang, Liu Fuyou, Dong Zheng, Sun Lin. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biology. 2017.
- He Mengdi, Feng Weiyi, Xu Chengchen, Cheng Zhitian, Yue Rensong, Yang Maoyi, Hu Zhipeng. Renal protective effects and mechanisms of tripterygium glycosides in animal models of diabetic nephropathy: a preclinical systematic review and meta-analysis. Frontiers in Pharmacology. 2026.
- Kitada Munehiro, Ogura Yoshio, Koya Daisuke. Rodent models of diabetic nephropathy: their utility and limitations. International Journal of Nephrology and Renovascular Disease. 2016.
- Alpers Charles E., Hudkins Kelly L.. Mouse Models of Diabetic Nephropathy. Current opinion in nephrology and hypertension. 2011.
- Nitta Kyoko, Shi Sen, Nagai Takako, Kanasaki Megumi, Kitada Munehiro, Srivastava Swayam Prakash, Haneda Masakazu, Kanasaki Keizo, Koya Daisuke. Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen. BioMed Research International. 2016.
- Zeng Zhitao, Shang Jiazhen, Chai Shouyu, Zhang Xia, Lv Xincong, Han Xiaotian, Xu Yifan, Ma Baoze, Lv Zhimei, Wang Rong. S100A1 Promotes MDM2 ‐Mediated KLF15 Ubiquitination to Regulate ID1 ‐Driven Tubular Injury in Diabetic Kidney Disease. The FASEB Journal. 2026.
- Zhang Zehao, Xiang Meijuan, Lan Lejian, Peng Duo, You Lixia, Jia Mengmeng, Peng Jianyun. Electroacupuncture ameliorates diabetic renal injury by regulating the AMPK-autophagy signaling pathway. Iranian Journal of Basic Medical Sciences. 2026.
- Hu Xiaofang, Chen Wei, Yang Ming, Li Mengwei, Li Xiangyi, Ouyang Shaxi. IGFBP5 promotes EndoMT and renal fibrosis through H3K18 lactylation in diabetic nephropathy. Cellular and Molecular Life Sciences: CMLS. 2025.
- Giralt-López Anna, Molina-Van den Bosch Mireia, Vergara Ander, García-Carro Clara, Seron Daniel, Jacobs-Cachá Conxita, Soler Maria José. Revisiting Experimental Models of Diabetic Nephropathy. International Journal of Molecular Sciences. 2020.
适用模型
常用模型严格来自已发布且已验证的疾病—模型关联。
db/db (Lepr^db)
C57BLKS 背景 db/db 模型用于糖尿病肾病研究,仅部分重现人类疾病特征。
已验证适用
模型完整资料eNOS 缺失 db/db 糖尿病肾病参考模型(文献参考)
糖尿病肾病与人类疾病相关性研究的文献参考模型(eNOS 缺失 db/db);适用性限于肾小球转录网络比较范围
已验证适用
模型完整资料db/db C57BLKS mouse
C57BLKS 背景 db/db 小鼠:尿白蛋白/ACR、肾小球系膜基质扩张与 GBM 增厚的 2 型糖尿病肾病模型
已验证适用
模型完整资料high-fat diet plus streptozotocin-induced type 2 diabetes C57BL/6J mouse
HFD+小剂量 STZ C57BL/6J 小鼠:ACR 升高、足细胞与纤维化终点
已验证适用
模型完整资料db/db mouse
db/db 小鼠(背景按各研究记载):白蛋白尿与肾小管线粒体损伤读出
已验证适用
模型完整资料OVE26 transgenic diabetic mouse
OVE26 转基因糖尿病小鼠:足细胞形态与转录改变、肾小球超微结构病变
已验证适用
模型完整资料streptozotocin-induced diabetes C57BL/6 mouse
STZ 糖尿病 C57BL/6 小鼠:HMGB1/系膜与小管间质终点
已验证适用
模型完整资料Akita mouse
Ins2 Akita 小鼠:1 型糖尿病白蛋白尿与肾小球病变
已验证适用
模型完整资料ob/ob BTBR mouse
BTBR ob/ob 小鼠:渐进白蛋白尿、GBM 增厚与系膜基质扩张的 2 型 DN 模型
已验证适用
模型完整资料BioBreeding (BB) rat
BB 大鼠:自发 1 型糖尿病肾小球病变(综述推荐)
已验证适用
模型完整资料Goto-Kakizaki rat
GK 大鼠:非肥胖型 2 型糖尿病肾损伤(模型综述推荐的白蛋白尿/病理读出)
已验证适用
模型完整资料KK-Ay mouse
KK-Ay 小鼠:肥胖胰岛素抵抗伴 KIM-1 相关小管脂质摄取与 DKD 进展
已验证适用
模型完整资料NOD mouse
NOD 小鼠:自身免疫 1 型糖尿病伴肾小球 PAS 病变(综述推荐)
已验证适用
模型完整资料Otsuka Long-Evans Tokushima Fatty (OLETF) rat
OLETF 大鼠:自发 2 型糖尿病肾大球硬化与小管间质纤维化(综述推荐)
已验证适用
模型完整资料streptozotocin-induced diabetic eNOS (Nos3) knockout mouse
低剂量 STZ 糖尿病 eNOS 缺失小鼠:系膜扩张、系膜溶解与进行性肾小球硬化(综述汇总证据)
已验证适用
模型完整资料streptozotocin-induced diabetes C57BL/6J mouse
STZ 糖尿病 C57BL/6J 小鼠:肾小管损伤与足细胞表型读出
已验证适用
模型完整资料streptozotocin-induced diabetes mouse
STZ 诱导糖尿病小鼠(品系按研究记载):白蛋白尿、GBM 增厚与系膜基质扩增
已验证适用
模型完整资料Zucker diabetic fatty (ZDF) rat
ZDF 大鼠:高脂喂养诱导的 2 型糖尿病肾渐进性病变(综述汇总)
已验证适用
模型完整资料alloxan-induced diabetes rat
四氧嘧啶糖尿病大鼠:白蛋白尿与肾小球病变(综述记载)
已验证适用
模型完整资料uninephrectomized db/db mouse (C57BLKS background)
UNX 后 db/db 小鼠:加速的蛋白尿、肾小管萎缩与间质纤维化
已验证适用
模型完整资料db/db mouse (C57BL/6 background)
C57BL/6 背景 db/db 小鼠:白蛋白尿与系膜基质扩张(较 BKS 缓和的 2 型 DN 背景)
已验证适用
模型完整资料high-fat diet plus streptozotocin-induced type 2 diabetes C57BL/6 mouse
HFD+STZ C57BL/6 小鼠:肾损伤与线粒体动力学终点
已验证适用
模型完整资料streptozotocin-induced diabetes DBA/2 mouse
STZ 糖尿病 DBA/2 小鼠:综述列为糖尿病肾小球病变易感品系
已验证适用
模型完整资料streptozotocin-induced diabetes Wistar rat
STZ 糖尿病 Wistar 大鼠:光生物调节/线粒体相关肾损伤读出
已验证适用
模型完整资料streptozotocin-induced diabetes rat
STZ 糖尿病大鼠:肾小球基底膜样物质积聚的经典 1 型 DN 大鼠模型
已验证适用
模型完整资料streptozotocin-induced diabetes Sprague-Dawley rat
STZ 糖尿病 SD 大鼠:白蛋白尿与肾小球/小管终点读出
已验证适用
模型完整资料t2dn/mcwi rat
T2DN/Mcwi 大鼠:自发性 2 型糖尿病肾病伴高血压与白蛋白尿(综述记载)
已验证适用
模型完整资料streptozotocin-induced diabetes TTRhRen mouse
TTRhRen 转基因 STZ 糖尿病小鼠:肾素过高表达加重的 DN 表型(综述记载)
已验证适用
模型完整资料high-fat diet-fed C57BL/6J mouse
HFD 高脂(含高果糖)C57BL/6J 背景:代谢紊乱伴早期肾小球改变
已验证适用
模型完整资料high-fat diet plus streptozotocin-induced type 2 diabetes mouse (adult induction)
成年 HFD+STZ 小鼠:FNDC5/线粒体完整性相关的糖尿病肾损伤
已验证适用
模型完整资料